Tennessee SB 733: Opioids - As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.

Status: Action deferred in Senate Health and Welfare Committee to 1/24/2024 (as of 2023-03-15)

State: Tennessee · Session: 113 · Bill: SB 733

Subjects: Opioids

Sponsors: Crowe

View Tennessee SB 733 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.